These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32649035)

  • 1. Development and validation of a novel 15-CpG-based signature for predicting prognosis in triple-negative breast cancer.
    Peng Y; Shui L; Xie J; Liu S
    J Cell Mol Med; 2020 Aug; 24(16):9378-9387. PubMed ID: 32649035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer.
    Gao Y; Wang X; Li S; Zhang Z; Li X; Lin F
    Med Sci Monit; 2021 May; 27():e930025. PubMed ID: 34003815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
    Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
    Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study.
    Qiu J; Peng B; Tang Y; Qian Y; Guo P; Li M; Luo J; Chen B; Tang H; Lu C; Cai M; Ke Z; He W; Zheng Y; Xie D; Li B; Yuan Y
    J Clin Oncol; 2017 Mar; 35(7):734-742. PubMed ID: 28068175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative Analysis of DNA Methylation and Gene Expression Profiles Identifies Colorectal Cancer-Related Diagnostic Biomarkers.
    Xu M; Yuan L; Wang Y; Chen S; Zhang L; Zhang X
    Pathol Oncol Res; 2021; 27():1609784. PubMed ID: 34366718
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
    Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
    J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer.
    Zheng J; Zhang YF; Han GH; Fan MY; Du MH; Zhang GC; Zhang B; Qiao J; Zhang SX; Cao JM
    Adv Ther; 2023 Jan; 40(1):310-330. PubMed ID: 36316558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
    Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y
    Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
    Fan CN; Ma L; Liu N
    J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG methylation signature predicts prognosis in breast cancer.
    Du T; Liu B; Wang Z; Wan X; Wu Y
    Breast Cancer Res Treat; 2019 Dec; 178(3):565-572. PubMed ID: 31520283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
    Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
    Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.
    Absmaier M; Napieralski R; Schuster T; Aubele M; Walch A; Magdolen V; Dorn J; Gross E; Harbeck N; Noske A; Kiechle M; Schmitt M
    Int J Oncol; 2018 Mar; 52(3):755-767. PubMed ID: 29328369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of whole-genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple-negative breast cancer.
    Xie G; Yang H; Ma D; Sun Y; Chen H; Hu X; Jiang YZ; Shao ZM
    Int J Cancer; 2019 Nov; 145(10):2850-2860. PubMed ID: 30977117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.
    Kleivi Sahlberg K; Bottai G; Naume B; Burwinkel B; Calin GA; Børresen-Dale AL; Santarpia L
    Clin Cancer Res; 2015 Mar; 21(5):1207-14. PubMed ID: 25547678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers.
    Liu X; Peng Y; Wang J
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32412047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel CpG-methylation-based nomogram predicts survival in colorectal cancer.
    Wang X; Wang D; Liu J; Feng M; Wu X
    Epigenetics; 2020 Nov; 15(11):1213-1227. PubMed ID: 32396412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic signature of non-small cell lung cancer based on TCGA methylation data.
    Wang Y; Wang Y; Wang Y; Zhang Y
    Sci Rep; 2020 May; 10(1):8575. PubMed ID: 32444802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel prognostic two-gene signature for triple negative breast cancer.
    Alsaleem MA; Ball G; Toss MS; Raafat S; Aleskandarany M; Joseph C; Ogden A; Bhattarai S; Rida PCG; Khani F; Davis M; Elemento O; Aneja R; Ellis IO; Green A; Mongan NP; Rakha E
    Mod Pathol; 2020 Nov; 33(11):2208-2220. PubMed ID: 32404959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
    Ramezani F; Salami S; Omrani MD; Maleki D
    Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 10-Gene Signature to Predict the Prognosis of Early-Stage Triple-Negative Breast Cancer.
    Kim CM; Park KH; Yu YS; Kim JW; Park JY; Park K; Yu JH; Lee JE; Sim SH; Seo BK; Kim JK; Lee ES; Park YH; Kong SY
    Cancer Res Treat; 2024 Oct; 56(4):1113-1125. PubMed ID: 38754473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.